Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Recruiting × IL32 protein, human × Clear all

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

pembrolizumab 95 Cyclophosphamide 71 Carboplatin 55 fludarabine 52 Injections 51 Bevacizumab 43 Gemcitabine 37 venetoclax 34 Paclitaxel 34 Nivolumab 34 Specimen Handling 33 Dexamethasone 33 Cisplatin 33 Magnetic Resonance Spectroscopy 31 Docetaxel 30 Biopsy 29 Temozolomide 23 toripalimab 22 atezolizumab 22 Pemetrexed 22 Irinotecan 22 Azacitidine 21 Oxaliplatin 20 Fulvestrant 20 Capecitabine 20 abemaciclib 19 Rituximab 18 Fluorouracil 18 Radiotherapy 17 Cetuximab 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04211675 2025-05-13

STING

Nationwide Children's Hospital

Phase 1/2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡